SIRPA and autoimmune disease: It is known that CD8a-SIRPα+ cDCs mainly induce CD4+ T cell responses, which is an important effector T cell population in autoimmune diseases, whereas CD8a+SIRPα- cDCs has greater ability to induce a CD8+ T cell response (9, 44, 46).